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Day of Dialogue: Mainstreaming Emergency Contraception in the National
Family Welfare Program
MEETING REPORT
3rd May 2013, Mumbai, India

Population Council in collaboration with Family Planning Association of India, hosted a Day of
Dialogue which addressed issues related to access, availability and use of emergency
contraception pills (ECP). Many senior medical and public health experts and pharmaceutical
managers got together to discuss issues related to mainstreaming of the pills and action to be
taken to ensure its availability to women who need it. Some of the key issues addressed in
this consultation include; provider knowledge on mechanism of action (MOA) and attitudes
towards (a) easy access to ECP and its link to pre-marital sex and promiscuity, (b) repeat use
of ECP, and (c) lack of information about ECP among potential users. Population Council
shared key findings of the recent study on knowledge, attitudes and opinion of gynecologists
and pharmacists on ECP use. The one-day consultation besides presenting national and
global issues surrounding ECP also had a panel on the role of pharmaceutical companies,
social marketing organizations and NGOs in increasing access of the product to all women
who need it at an affordable price and are aware of its correct use. Another panel discussed
the role of the public sector and medical associations in mainstreaming ECP in the National
Family Welfare Program. This report condenses the deliberations and propositions for follow
up actions put forward at the consultation.
1

Global overview and recent progress
Currently ECP brands are registered in 144 countries. In USA, ECPs were approved for
prescription use in 1999. Recently, the FDA also approved ECP as an OTC for women over
15 years. A major barrier to making access easier has been the ambiguity of MOA. Latest
research on most commonly used Levonorgestrel ECPs, suggests that interference with
ovulation is the primary and possibly the only mechanism of action. ECPs do not have any
effects after fertilization or on implantation of a fertilized egg. Moreover, repeated use of ECP
has no serious health risks (ICEC & FIGO). These recent findings have an enormous
contribution to making ECP access easier.

National overview: Use and knowledge of ECP is low and skewed towards urban areas
The NFHS-3 shows high unmet need (21 percent), high unwanted pregnancy (25 percent) but
low awareness of ECP (less than 30 percent) and use (less than 1 percent). India also has a
high Maternal Mortality Rate of which 9 percent is due to abortion complications. Given these
indicators, ECP was introduced in National Family Welfare Program in 2002 and made an
OTC drug in 2005. In 2008 the Govt. of India piloted ECP introduction in the public health
system by making CHWs the depot holder of ECP. Even though ECP is an innovative and
unique method that gives one last chance to prevent unwanted pregnancy, the awareness
and use of ECP remains low. India’s Essential Medicines List still does not include ECPs, nor
does it include any contraceptives. Overall, the average level of ECP knowledge across states
was 14 percent, but ECP knowledge varies greatly by state, with several states having levels
lower than 5 percent and other having levels above 25 percent. Provider knowledge is also
uneven and often low. Pharmaceutical shop audit data shows a growing demand of ECP in
India but with a very skewed high growth in large metros and a poor growth in rural areas.

Gynecologists’ knowledge and reservations
Gynecologists have strong influence on policymaking and uptake among beneficiaries and
hence have major role in mainstreaming of ECP. Council’s study examined providers’
(gynecologists, pharmacists and paramedics) knowledge, attitudes and practices towards
ECP and its provision. They found that there is a lack of knowledge about the mechanism of
action and misconceptions about side effects and opposition from some gynecologists to
provision of ECP as an OTC and by ASHAs. Majority (95 percent) of the gynecologists
incorrectly believed that ECP works by preventing implantation. So their knowledge of MOA is
not up to date information. Some have the misconception that ECP could lead to abortion.
Gynecologists also have reservations about ECP provision as prophylactic, as an OTC, by
CHWs and without an age restriction. They believed that women who use ECP are more
promiscuous, have premarital sex, do not use regular FP, have STDs and have risky sexual
behavior. Most said that married women and women who have infrequent or unprotected sex
can use ECP but fewer said unmarried adolescents can use ECP. Most were in favor of one
time use of ECP in same menstrual cycle but there is still ambiguity to what counts as
repeated use and its side effects. Qualitative data shows that gynecologists believe abortion
has gone down but there is a need for a good prospective study to assess whether easy
access to ECP will decrease unwanted pregnancies and need of abortion. In recent years,
newspapers and magazines have published articles with negative quotes by gynecologists
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which further vitiate the mind of the community.
There is a need for an educational campaign on awareness, repeated use and its unreliability
if used as regular FP method. FOGSI and other medical associations should remove
misconception about MOA among its members and their reservations on OTC and provision
by CHWs. FOGSI, through their journal and print material like a 1 page editorial article can
take a proactive role. However, improving of gynecologists’ knowledge on MOA will not
address their negative attitudes. We have to address the gynecologists’ fears and
misconceptions together to address this issue. The bias is not only in gynecologists but also
amongst policy makers. Sensitization of all stakeholders is needed to affect their biases
against ECP users. The FOGSI theme for the year 2013 is “innovation to implementation”.
With the Population Foundation of India, they are making a resource for all doctors who must
know at least the basics of contraception. They feel the need to focus on limiting population
now more than other issues.

Users knowledge
Evidence from DHS and gynecologists experience indicates low knowledge of ECP among
users. During the deliberations, a top ECP selling pharmaceutical company, Piramal reported
that their study found many sexual health myths among users like eating papayas and
washing up after sex will prevent pregnancy. The Urban Health Initiative in Uttar Pradesh
showed CPR increase from 46 percent to 49.8 percent but ECP impact on CPR remained low.
Of the 17,643 women of reproductive age in 6 cities who were asked about their current use
of FP methods, only 7 mentioned ECPs. ECPs were sometimes confused with abortion pills.
Younger and educated women were found to be more aware of ECP. The study also showed
that women hid ECP use. There were irregular supplies at Govt. public health post, and
community health days were used to provide supplies. Work done by Janani and UHI
increased sales, and private facilities availability was made more visible. Responsible and
accurate mass media was used to improve awareness.
The discussion emphasized that emotions of women, who are in the moment of panic after an
act of unprotected sex, have the right to access ECP in that moment. The consultation
suggested many ways to reach the users. The Government’s ARSH program has started
introducing sex education at schools to inform adolescents and young women and men.
Correct knowledge on ECP also should be introduced and educated at schools not in the
gynecologists’ office. Counseling is a preventive approach which needs to be ensured in all
areas of RH. This could also be utilized as an opportunity to inform about regular methods
(OCP, condoms, IUD). It was debated that, girls today do not go to gynecologists, only to the
shop to get ECP if they have had sex and are at risk of unwanted pregnancy. It may not be
possible to do a national level campaign with pharmacists, so organizations can equip
pharmacists with basic ability to guide women on ECP usage. The leaflet accompanying the
pill should have few simple worded lines.
The Piramal sales team runs an education drive distributing leaflets for pharmacists. But the
challenge is that the sales team members are not trained to work on knowledge and attitudes
of the providers whom they are in contact with. Piramal records user data from emails and
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phone calls at the customer care center about ‘i-pill’ which are responded to by group of
psychologists from an NGO called Avishkar.
There is a need for public sector engagement for awareness, ECP provision and integration in
other RH services. The varying civil society organizations have a critical role to play to direct
young users. Specific roles need to be identified in advocacy and service delivery processes
where innovation and learning’s can come in.

Pharmacists’ knowledge and attitudes
The Council study surveyed pharmacists in UP on their (i) knowledge on the mechanism of
action (MOA), safety and effectiveness of ECP, (ii) their attitudes to ECP, its users, concerns
about ECP use and its repeated use. Many pharmacists felt that unmarried women can use
ECP (62 percent). Most reported no challenges in providing ECP and did not feel the need for
any training or material to provide ECP (80 percent). However, most of the pharmacists in
general had negative attitudes towards ECP and its users -74 percent believed that it easy
access is leading to premarital sex and 46 percent believed it is leading to promiscuity. They
also supported restriction is age for providing ECP and felt that majority of their clients were
unmarried boys and girls. Despite of that they were happy to stock ECP because of its
growing demand and good commission that they receive per pack of ECP. The participants
felt that there is a need for advocacy with pharmaceutical associations to orient them on
correct knowledge and display IEC material, address their negative attitudes towards ECP
use, provide leaflets to clients at pharmacy and sensitize media to project ECP correctly.
ICEC has prepared very concise brief for pharmacists and other providers’ which are open for
sharing and could be used for this purpose. Questions were raised on feasibility of using
pharmacists to provide information to their clients due to lack of privacy and time.
Panelists believed that in rural areas and smaller towns, though the pharmacists may have
time and space for information dissemination, but high cost of ECP leading to poor demand of
the method discourage them to invest in stocking ECP. Hesitation of woman to disclose
unprotected sex to pharmacist of her own village/locality also could act as barrier to free
access. HLL’s and PSI’s experience shows that social marketing firms could play significant
role in provision of correct knowledge of ECP and increasing its demand among women in
need but mostly avoid it as working in rural areas is challenging and has a limited profitability.

Advertising
The ban on ECP advertising was put in place because of aggressive advertising for brand
promotion. Careful advertising is needed for knowledge dissemination, and non-judgmental
portrayal of the user. Abortion pills are under the MoHFW’s ‘Schedule F’ which means they
cannot be advertised directly or indirectly, ECPs are under ‘Schedule K’ which means they
can be advertised even though the ban has hindered this. The ban lead to a 50 percent
decrease in sale, also because of side effects since retailers did not know the dosage and
timing of ECP.

Supply
A presentation revealed that supply of ECP to ASHA is mostly in short who are supposed to
provide ECP at the door step of people in rural areas and could charge Rs two as service fee.
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The AC Nielsen ORG MARG shop audit data shows that there is a big difference in sale of
ECP in urban vs. rural areas. 68 percent of the total ECP sale is in urban areas and 32
percent in rural, accounting for the 70 percent population. This is indicates a general lack of
knowledge about the method and its limited supply through pharmacies.

Mainstreaming ECP
In the conference mainstreaming of ECP was defined as its easy accessibility at affordable
price, with the basket of contraceptive choice. While it is emphasized that ECP is more a
backup method in case of unprotected sex, women should be free to access and use it with
knowledge that ECP failure rate is much higher than regular modern contraceptives. Further, it
also includes provision of its correct knowledge and meeting the needs of all women including
sexually active adolescents, irrespective of marital status. Innovative ways are needed to
educate ASHAs on the range of methods (such as by mobile phones). For example, in a
distance-learning course, ASHA has to pay Rs.85 and surprisingly it has a high enrollment.
Besides public sector, NGOs and civil society organizations have equally important role in
educating women about the correct use of ECP. They could play an active role for advocating
mainstreaming of ECP, regular supply of the method to ASHAs and liberalization of its
advertisement using three 3E rules of advocacy; Evidence (numbers and facts count),
Emotion (appeal to people’s emotions and feelings), and Eminent (have an influential person
behind your advocacy).

Way Forward
• Awareness campaign: Increasing knowledge (especially for youth) should include
information on ECP and also on abortion pills and OCPs since there are
misconceptions as what is to be used under what circumstances. Both women and men
should be the target of any such efforts.
• Supply in rural areas and advocacy for public sector: As the present commercial viability of
ECP is limited in rural India, public sector has to ensure regular and adequate supply of
ECP to ASHAs. Given the limitation of the supply chain of public sector, supply of
contraception directly to ASHAs could be outsourced to a private partner and closely
monitored, as possible alternative.
• Removing medical barrier: Advocacy and involvement of medical association like FOGSI
and IMA is needed to reduce the medical barriers and negative attitudes of doctors and
pharmacists towards use of ECP and its users. Journalists, pharmaceuticals, and
advertising companies need to be involved to disseminate responsible messages.
Special sessions, newsletters and their journals, social media and internet can be used
by FOGSI to sensitize doctors and provide updates on MOA. NGOs and civil societies
could also play an important role both as advocating agency and providers of correct
knowledge to all stakeholders—providers, potential users and policy makers.
• Further research: Studies on contraceptive use pattern particularly ECP among young
unmarried and newly married couples’ decision making process, sources of information
and their information need could help in increasing contraceptive use and appropriate
use of ECP among young men and women. It has been stipulated that easy
accessibility of ECP may increase risk behavior/repeat use among adolescents, which
also needs careful examination.
• Overall wellbeing of women: A holistic approach in needed on improving the overall
wellbeing and quality of life of women, starting with basic healthcare and then including
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contraception use. Counseling, IEC/BCC or advertising, need to be people centric and
give importance to all available contraceptive methods to meet the needs of each
segment of the population. The higher goal is to reduce maternal mortality and
morbidity.
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AGENDA
Mainstreaming Emergency Contraception in the National Family Welfare Program
May 3, 2013
Venue: Terrace Hall, West End Hotel Mumbai, India
09:30 am – 9: 50 am

Registration

9:50 am -10:35 am

WELCOME AND INAUGURAL SESSION

9:50 am – 10:00 am

Welcome: Mr. Vishwanath Koliwad, Secretary General, FPA India

10:00 am – 10:10 am

Context and Purpose of the Meeting: Dr. M.E. Khan, Senior Associate, Population
Council

10:10 am – 10:20 am

Opening Remarks: Dr. S.K. Sikdar, Deputy Commissioner, In-charge FP,
Research Studies and Standards, Ministry of Health and Family Welfare

10:20 am – 10:35 am

Inaugural Address: Sh. Jayant Kumar Banthia, Principal Secretary, Public Health
Department, Govt. of Maharashtra

10:35 am – 12:30 pm

SESSION I: Global and national overview

10:35 am – 10:55 am

Moderators: Dr. R.P. Soonawala, Senior Gynecology Consultant
Dr. Suneeta Sharma ,Country Director, Futures Group
Global perspective and recent developments on ECP in USA
Ms. Sarah Rich, Program Officer, International Consortium for Emergency
Contraception
Gynecologists’ knowledge, attitudes and practices influencing access to ECP
Ms. Anvita Dixit, Assistant Program Officer, Population Council

10:55 am – 11:15 am
11:15 am – 11:35 am

Experience of the Urban Health Initiative (UHI) in providing ECP
Dr. Rajni Wadhwa, Technical Specialist, UHI, FHI 360

11:35 am – 11:55 am

Pharmacists’ knowledge, attitudes and practices influencing access to ECP
Ms. Isha Bhatnagar, Program Officer, Population Council

12:15 pm – 12:30 pm

Discussion
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12:30 pm – 1:30 pm

SESSION II: Role of pharmaceutical companies, social marketing organizations
and NGOs in increasing access to ECP
Moderators:
Dr. Daya Krishan Mangal, State Programme Coordinator, UNFPA Maharashtra
Ms. Priya Jha, Country Representative, Institute for Reproductive Health,
Georgetown University
Panelists:
Mr. Sachin Rajpal, General Manager Marketing, Consumer Products Division,
Piramal Enterprises Ltd.
Dr. Sandeep Ghiya, Freelance Consultant
Dr. Kalpana Apte, Assistant Secretary General (Program Implementation), FPA
India
Mr. Naveen Kumar Bansal, General Manager Sales, Population Services
International
Discussion

1:30 pm – 2:15 pm
2:15 pm – 3:30 pm

3:30 pm – 3:50 pm
3:50 pm – 4:00 pm

LUNCH
SESSION III: Role of public sector and medical associations in mainstreaming
access to ECP
Moderators: Dr. Usha R. Krishna, Senior Gynecology Consultant
Dr. Rita Leavell, Chief of Party, Improving Health Behaviors Program, FHI 360
Panelists:
Dr. R. P. Soonawala, Senior Gynecology Consultant
Dr. S.K. Sikdar, Deputy Commissioner, Research Studies and Standards, Ministry of
Health and Family Welfare
Dr. Hema Divakar, President, FOGSI
Prof. Jay K. Satia, Senior Director (Academics), Public Health Foundation of India
Discussion
Concluding Remarks
Dr. Kumudha Aruldas, Program Associate, Population Council
Vote of thanks
Ms. Bindiya Nimla, Director - Advocacy and Training, FPA India
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Shiv Kumar
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jsatia@iiphg.org
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Dr. Manisha Bhise

FPA India

manishabhise@fpaindia.org
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Dr. Rita Leavell

IHBP/FHI 360

rleavell@fhi360.org

10.

Rajni Wadhwa

UHI

rwadhwa@uhi-india.org

11.

Sharmistha K

FHI 360

skhobragade@fhi360.org

12.
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FHI 360, Delhi

ssen@fhi360.org

13.

Chander Shekhar
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Lysander Menezes

PATH, Delhi
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Consultant
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18.
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19.
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FPA India

kranti@fpaindia.org

20.
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FPA India
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IntraHealth International
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22.
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Population Services International
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23.
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FPA India
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25.
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Georgetown University
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36.
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37.
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39.
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FPA India
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